Cargando…

Inhibitor-Sensitive FGFR1 Amplification in Human Non-Small Cell Lung Cancer

BACKGROUND: Squamous cell lung carcinomas account for approximately 25% of new lung carcinoma cases and 40,000 deaths per year in the United States. Although there are multiple genomically targeted therapies for lung adenocarcinoma, none has yet been reported in squamous cell lung carcinoma. METHODO...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dutt, Amit, Ramos, Alex H., Hammerman, Peter S., Mermel, Craig, Cho, Jeonghee, Sharifnia, Tanaz, Chande, Ajit, Tanaka, Kumiko Elisa, Stransky, Nicolas, Greulich, Heidi, Gray, Nathanael S., Meyerson, Matthew
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2011
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3110189/ https://www.ncbi.nlm.nih.gov/pubmed/21666749 http://dx.doi.org/10.1371/journal.pone.0020351

Ejemplares similares

Ligand associated ERBB2/3 activation confers acquired resistance to FGFR inhibition in FGFR3 dependent cancer cells
por: Wang, Jun, et al.
Publicado: (2014)

FGFR2 amplification in colorectal adenocarcinoma
por: Carter, Jamal H., et al.
Publicado: (2017)

FGFR1 amplification and the progression of non-invasive to invasive breast cancer
por: Gru, Alejandro A, et al.
Publicado: (2012)

Characterization of DDR2 Inhibitors for the Treatment of DDR2 Mutated Nonsmall Cell Lung Cancer
por: Terai, Hideki, et al.
Publicado: (2015)

Incidence of FGFR2 Amplification and FGFR2 Fusion in Patients with Metastatic Cancer Using Clinical Sequencing
por: Hyung, Sujin, et al.
Publicado: (2022)

Resistance to allosteric SHP2 inhibition in FGFR-driven cancers through rapid feedback activation of FGFR
por: Lu, Hengyu, et al.
Publicado: (2020)

Genomic insights into the mechanisms of FGFR1 dependency in squamous cell lung cancer
por: Mäkinen, Netta, et al.
Publicado: (2023)

FGFR2 gene amplification and clinicopathological features in gastric cancer
por: Matsumoto, K, et al.
Publicado: (2012)

Frequent 4EBP1 Amplification Induces Synthetic Dependence on FGFR Signaling in Cancer
por: Mohan, Prathibha, et al.
Publicado: (2022)

Somatic mutations are present in all members of the AKT family in endometrial carcinoma
por: Dutt, A, et al.
Publicado: (2009)

FGFR1 amplification in breast carcinomas: a chromogenic in situ hybridisation analysis
por: Elbauomy Elsheikh, Somaia, et al.
Publicado: (2007)

FGFR-1 amplification in metastatic lymph-nodal and haematogenous lobular breast carcinoma
por: Brunello, Eleonora, et al.
Publicado: (2012)

FGFR2 amplification is predictive of sensitivity to regorafenib in gastric and colorectal cancers in vitro
por: Cha, Yongjun, et al.
Publicado: (2018)

Circulating Tumor DNA Analysis Detects FGFR2 Amplification and Concurrent Genomic Alterations Associated with FGFR Inhibitor Efficacy in Advanced Gastric Cancer
por: Jogo, Tomoko, et al.
Publicado: (2021)

COVID-19: Advances in diagnostic tools, treatment strategies, and vaccine development
por: Sreepadmanabh, M, et al.
Publicado: (2020)

Expression of FGFR3 Protein and Gene Amplification in Urinary Bladder Lesions in Relation to Schistosomiasis
por: Hammam, Olfat, et al.
Publicado: (2017)

Cancer-related FGFR2 overexpression and gene amplification in Japanese patients with gastric cancer
por: Minashi, Keiko, et al.
Publicado: (2021)

FGFR1 amplification or overexpression and hormonal resistance in luminal breast cancer: rationale for a triple blockade of ER, CDK4/6, and FGFR1
por: Mouron, Silvana, et al.
Publicado: (2021)

Gastric carcinosarcoma with FGFR2 amplification under long-term control with pazopanib: a case report and literature review
por: Hayashi, Hirokatsu, et al.
Publicado: (2022)

Gene amplification of EGFR, HER2, FGFR2 and MET in esophageal squamous cell carcinoma
por: KATO, HIROAKI, et al.
Publicado: (2013)

Prognostic role of FGFR1 amplification in early-stage non-small cell lung cancer
por: Cihoric, N, et al.
Publicado: (2014)

Absence of amplification of the FGFR1-gene in human malignant mesothelioma of the pleura: a pilot study
por: Plönes, Till, et al.
Publicado: (2014)

GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers
por: Mermel, Craig H, et al.
Publicado: (2011)

SARS-CoV-2: phylogenetic origins, pathogenesis, modes of transmission, and the potential role of nanotechnology
por: Sahu, Amit Kumar, et al.
Publicado: (2021)

Autophosphorylation of the carboxyl‐terminal domain is not required for oncogenic transformation by lung‐cancer derived EGFR mutants
por: Cho, Jeonghee, et al.
Publicado: (2018)

A Pan-Cancer Analysis of Transcriptome Changes Associated with Somatic Mutations in U2AF1 Reveals Commonly Altered Splicing Events
por: Brooks, Angela N., et al.
Publicado: (2014)

FGFR1 Amplification Is Often Homogeneous and Strongly Linked to the Squamous Cell Carcinoma Subtype in Esophageal Carcinoma
por: von Loga, Katharina, et al.
Publicado: (2015)

FGFR1 and HER1 or HER2 co-amplification in breast cancer indicate poor prognosis
por: Chen, Shinan, et al.
Publicado: (2018)

Pathologic and prognostic impacts of FGFR2 amplification in gastric cancer: a meta-analysis and systemic review
por: Kim, Hyeong Su, et al.
Publicado: (2019)

Impact of fibroblast growth factor receptor 1 (FGFR1) amplification on the prognosis of breast cancer patients
por: Erber, Ramona, et al.
Publicado: (2020)

Oncogenic FGFR1 mutation and amplification in common cellular origin in a composite tumor with neuroblastoma and pheochromocytoma
por: Tasaka, Keiji, et al.
Publicado: (2022)

Prognostic value of FGFR1 expression and amplification in patients with HNSCC: A systematic review and meta-analysis
por: Hu, Yao, et al.
Publicado: (2021)

Inhibition of the fibroblast growth factor receptor (FGFR) pathway: the current landscape and barriers to clinical application
por: Chae, Young Kwang, et al.
Publicado: (2016)

SERINC5 Mediates a Postintegration Block to HIV-1 Gene Expression in Macrophages
por: Ramdas, Pavitra, et al.
Publicado: (2023)

Erratum for Ramdas and Chande, “SERINC5 Mediates a Postintegration Block to HIV-1 Gene Expression in Macrophages”
por: Ramdas, Pavitra, et al.
Publicado: (2023)

Prognostic Value of FGFR Gene Amplification in Patients with Different Types of Cancer: A Systematic Review and Meta-Analysis
por: Chang, Jinjia, et al.
Publicado: (2014)

High amplification of FGFR1 gene is a delayed poor prognostic factor in early stage ESCC patients
por: Song, Qi, et al.
Publicado: (2017)

Peritoneal Seeding Is More Common in Gastric Cancer Patients with FGFR2 Amplification or High Tumor Mutation Burden
por: Kim, Hyunjin, et al.
Publicado: (2022)

FGF/FGFR genomic amplification as a predictive biomarker for immune checkpoint blockade resistance: a short report
por: Roussot, Nicolas, et al.
Publicado: (2023)

From Entry to Egress: Strategic Exploitation of the Cellular Processes by HIV-1
por: Ramdas, Pavitra, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_01356f5rihfvcaspmepfq3mjku